Literature DB >> 6432553

Alcohol and bupropion pharmacokinetics in healthy male volunteers.

J Posner, A Bye, S Jeal, A W Peck, P Whiteman.   

Abstract

A study was performed to determine whether there is a pharmacokinetic interaction between alcohol and the novel antidepressant bupropion. In the first part 8 healthy male volunteers received single doses of 100 mg bupropion hydrochloride orally on 2 occasions accompanied by either ethanol in orange or plain orange drink according to a balanced cross over design. Plasma bupropion concentrations were determined by radioimmunoassay and kinetics analysed with the aid of NONLIN. Blood alcohol levels were assessed by breathalyser. The disposition of bupropion was adequately described by a 2 compartment model and kinetic parameters were not significantly altered by the presence of alcohol. In the second part of the study the same subjects received 40 ml ethanol in orange drink 3.5 h after ingestion of 100 mg bupropion or dummy tablet in a double blind cross over fashion. Bupropion did not affect alcohol kinetics. In contrast to many other psychotropic drugs there is no evidence for a kinetic interaction between bupropion and alcohol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432553     DOI: 10.1007/bf00543497

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

2.  Precision, accuracy and relevance of breath alcohol measurements.

Authors:  A W Jones
Journal:  Mod Probl Pharmacopsychiatry       Date:  1976

3.  Diazepam actions and plasma concentrations following ethanol ingestion.

Authors:  S M MacLeod; H G Giles; G Patzalek; J J Thiessen; E M Sellers
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

4.  Effect of tricyclic antidepressants and alcohol in psychomotor skills related to driving.

Authors:  T Seppälä; M Linnoila; E Elonen; M J Mattila; M Mäki
Journal:  Clin Pharmacol Ther       Date:  1975-05       Impact factor: 6.875

5.  Inhibition of drug metabolism by acute ethanol intoxication. A hepatic microsomal mechanism.

Authors:  E Rubin; H Gang; P S Misra; C S Lieber
Journal:  Am J Med       Date:  1970-12       Impact factor: 4.965

6.  Ethanol 'dose-dependent' elimination: Michaelis-Menten v classical kinetic analysis.

Authors:  R E Rangno; J H Kreeft; D S Sitar
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

7.  Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction.

Authors:  P Dorian; E M Sellers; K L Reed; J J Warsh; C Hamilton; H L Kaplan; T Fan
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Alcohol absorption, gastric emptying and a breathalyser.

Authors:  S Holt; M J Stewart; R D Adam; R C Heading
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

9.  Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects.

Authors:  J W Findlay; J Van Wyck Fleet; P G Smith; R F Butz; M L Hinton; M R Blum; D H Schroeder
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Hepatic microsomal enzymes in man and rat: induction and inhibition by ethanol.

Authors:  E Rubin; C S Lieber
Journal:  Science       Date:  1968-11-08       Impact factor: 47.728

View more
  10 in total

Review 1.  Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation.

Authors:  Andrew J Johnston; John Ascher; Robert Leadbetter; Virginia D Schmith; Dipak K Patel; Michael Durcan; Beth Bentley
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

Review 3.  Bupropion: a review of its use in the management of smoking cessation.

Authors:  K J Holm; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  Co-Administration of Low-Dose Naltrexone and Bupropion Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats.

Authors:  Emily R Nicholson; Julian E Dilley; Janice C Froehlich
Journal:  Alcohol Clin Exp Res       Date:  2018-01-22       Impact factor: 3.455

5.  Sex differences in the effect of bupropion and naltrexone combination on alcohol drinking in mice.

Authors:  Yan Zhou; Francesco Leri; Malcolm J Low; Mary Jeanne Kreek
Journal:  Pharmacol Biochem Behav       Date:  2019-04-13       Impact factor: 3.533

6.  Effect of hepatic and renal dysfunction on disposition of bupropion in rats.

Authors:  J S Kaka; K I Al-Khamis; M O Tanira
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jul-Sep       Impact factor: 2.441

Review 7.  Comparative tolerability profiles of the newer versus older antidepressants.

Authors:  M V Rudorfer; H K Manji; W Z Potter
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

Review 8.  Consensus statements on the clinical understanding and use of bupropion in Hong Kong.

Authors:  Wing-King Lee; Kwok-Leung Au Yeung; Ho-Bun Lam; Chi-Keung Wong; Ting-Chi Wong; Chi-Kin Fu; Shiu-Kow Sham; Ming-Kai Au; Tat-Chung Lam; Daniel Ki-Yan Mak
Journal:  CNS Neurosci Ther       Date:  2021-03       Impact factor: 5.243

9.  Alcohol significantly lowers the seizure threshold in mice when co-administered with bupropion hydrochloride.

Authors:  Peter H Silverstone; Robert Williams; Louis McMahon; Rosanna Fleming; Siobhan Fogarty
Journal:  Ann Gen Psychiatry       Date:  2008-08-18       Impact factor: 3.455

10.  Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network.

Authors:  Fatima Zahra Marok; Laura Maria Fuhr; Nina Hanke; Dominik Selzer; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2021-03-04       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.